The Charles T. Campbell Eye Microbiology Lab
UPMC | University of Pittsburgh Medical CenterUniversity of Pittsburgh Schools of the Health Sciences
HomeAbout UsLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchContact Us

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2003 Abstracts and Meeting Agenda

Scientific Session
Sheraton Anaheim Hotel
London East and West Room
November 15, 2003

Moderator: Regis P. Kowalski

7:00 a.m. Registration (Rotunda)

7:30 a.m. Abs.# 1 The In-Vitro Evaluation of the Ophthalmic Fluoroquinolones Against Bacterial Conjunctivitis Isolates
E.G. Romanowski, R.P. Kowalski, K.A. Yates, F.S. Mah, Y.J. Gordon

7:37 a.m. Abs.# 2: In-Vitro Susceptibility and Minimal Inhibitory Concentration Data for Ocular Pathogens for Gatifloxacin in Comparison With 4 Other Fluoroquinolones
B. Fouraker, M. Callegan, M. Desjardins, H. Perry, L. Villanueva, H. Jensen

7:44 a.m. Abs.# 3: The Successful Treatment of Gatifloxacin-Resistant Staphylococcus aureus Keratitis with Gatifloxacin (Zymar) in a NZW Rabbit Model
F.S. Mah, E.G. Romanowski, K.A. Yates, R.P. Kowalski, Y.J. Gordon

7:51 a.m. Abs.# 4 In -Vitro Resistant Rates for Fluoroquinolones Against Methicillin-Sensitive (MS) and Methicillin Resistant (MR) Staphylococcus aureus Ocular Isolates
D. Miller, M. Diaz, E. Perez, E. Alfonso

7:58 a.m. Abs.# 5: Do Flies Transmit Trachoma?
K. Miller, N. Pakpour, E. Yi, M. Melese, W. Alemayehu, M. Bird, G. Schmidt, V. Cevallos, L. Olinger, J Chidambaram, J. Whitcher, T. Lietman

8:05 a.m. Abs.# 6: Elimination May Not Be Too High a Goal For Trachoma Programs
B. Gaynor, H. Jha, K. Miller, E. Yi, J. Chidambaram, S. Osaki-Holm, J. Whitcher, T. Lietman

8:12 a.m. Abs.# 7: Pseudomonas Radial Keratoneuritis
J.F. Freitas, S.A. Baxter, C.J.Rapuano, P.R. Laibson, E.J. Cohen

8:19 a.m. Abs# 8: Serratia Corneal Ulcers: A Retrospective Clinical Study
J. H. Mah-Sadorra, D.M.Najjar, C.J. Rapuano, P.R. Laibson, E.J. Cohen

8:26 a.m. Abs.# 9: The Effect of Cataract Surgery on Antibiotic Ocular Penetration
R. Mather, J. Stewart, Tisha Prabriputaloong, Joshua Wong, Stephen D. McCleod

8:33 a.m. Abs.# 10: Human Aqueous Humor Penetration Pharmacokinetics of Moxifloxacin After Topical Administration of Moxifloxacin 0.5% Ophthalmic Solution
H. Katz, S. Masket, S. Lane, K. Sall, S. Orr, B. McCue, R. Faulkner, D. Dahlin

8:40 a.m. Abs.# 11: The Prevention of Bacterial Endophthalmitis by Topical Moxifloxacin in a Rabbit Prophylaxis Model
R.P. Kowalski, E.G. Romanowski, F.S. Mah, K.A. Yates, J.S. Gordon

8:47 a.m. Abs.# 12: Intraocular Safety of Gatifloxacin in a Rabbit Model
R.W. Snyder, M. Chang, W. Hare, M. Stern, E. Donnenfeld, T. Kramer

8:54 a.m. Abs.# 13: Fungal Colonization of Keratoprosthesis
S.D. Barnes, C.H. Dohlman, B. Paton, M.L. Durand

9:01 a.m. Abs.# 14: Will Voriconazole Become the Antifungal of Choice in the Treatment of Corneal Yeast Infection?
M. Shah, D. Ritterband, M. Rhee, T. Kaiura, W. Perez, R. Koplin, J. Seedor

9:08 a.m. Abs.# 15: Comparison of Fungal Contamination in Benzalkonium Chloride (BAK) Preserved and BAK Free Fluoroquinolone Antibiotics
M. Rhee, D. Ritterband, M. Shah, W. Perez, T. Kaiura, R. Koplin, J. Seedor

9:15 a.m. Abs.# 16: The Antimicrobial Preservative Efficacy of Zymar and Vigamox Against Yeast Isolates
D. Rupp, T. Reeves, S. Kapadia, C. Anger

9:22 a.m. Abs.# 17: Ocular Surface Squamous Neoplasia: The Standard of Care Survey
D.U. Stone, J. Chodosh

9:29 a.m. Abs.# 18: The Microbial Flora From Explanted Punctal Plugs
S.H. Soukiasian

9:36 a.m. Abs.# 19: The Reliability of Transport Medium for Corneal Ulcer Culture and Microbiological Investigations: A Clinical Comparison with Direct Plate Inoculation
A.B. Kumar, V. Cevallos, M. Srinivasom, J.P. Whitcher, S.D. Mcleod

9:43 a.m. Abs.# 20: Microbial Keratitis After Amniotic Membrane Grafting (AMG)
P. Garg, K. Srivalli, S. Sharma, G.N. Rao

9:50 a.m. Abs.# 21: The Threat of Atypical Mycobacteria in Ophthalmology
B.A. Schlech, D.W. Stroman, E. Alfonso, K. Wilhelmus, R.L. Abshire

9:57 a.m. Abs.# 22: Effectiveness of Fluoroquinolone Antibiotics for Experimental Mycobacterium chelonae Keratitis
A.R. Caballero, B.A. Thibodeaux, J.J. Dajcs, M.E. Marquart, K.H. Johnston, J.T. Bush and R.J. O’Callaghan.

10:04 a.m. Abs.# 23: Expression Profile of Transcriptional Regulators in Cornea in a Mouse Model of Infectious Keratitis
J.Y. Hyon, S.Hose, D. Sinha, T. O'Brien

10:11 a.m. Abs.# 24: Safety of Prophylactic Intracameral Gatifloxacin in Cataract Surgery
E.D. Donnenfeld, R.W. Snyder, A.J. Kanellopoulos, H.D. Perry, C. Cheng, J. Wittpenn, C. Roberts

10:17 a.m. THYGESON LECTURE - Richard K. Forster, M.D.
The Correlation of Microbiology and Pathology in Experimental Endophthalmitis as a Prelude to Focused Therapy

10:42 a.m. Closing Comments and Awards

10:45 a.m. END

Back to OMIG Main Page

Top of Page

Web Site Terms of Use | E-mail Terms of Use | Medical Advice Disclaimer
UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences | Contact UPMC